Bevacizumab Plus Irinotecan–Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

Author： Yildiz Ramazan   Buyukberber Suleyman   Uner Aytug   Yamac Deniz   Coskun Ugur   Kaya Ali Osman   Ozturk Banu   Yaman Emel   Benekli Mustafa  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.1, 2010-01, pp. : 33-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer

By Nakayama Goro   Tanaka Chie   Uehara Keisuke   Mashita Naoki   Hayashi Naomi   Kobayashi Daisuke   Kanda Mitsuro   Yamada Suguru   Fujii Tsutomu   Sugimoto Hiroyuki   Koike Masahiko   Nomoto Shuji   Fujiwara Michitaka   Ando Yuich   Kodera Yasuhiro  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 847-855

Springer Publishing Company

Access to resources Recommend Favorite

Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin

By                                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1029-1034

Science Publishers

Access to resources Recommend Favorite

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

By Sørbye Halfdan   Berglund Åke   Tveit Kjell Magne   Øgreid Dagfinn   Wanderås Eva Hoff   Wentzel-Larsen Tore   Dahl Olav   Glimelius Bengt  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 982-988

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite